Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments.
Journal article
Cake C. et al, (2022), Trials, 23
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2022)
Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2022)
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial-Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical Trial.
Journal article
Harper C. et al, (2021), JAMA network open, 4
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
Horby PW. et al, (2021), Lancet Respiratory Medicine, 9, 1419 - 1426
Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention
Presentation
Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.
Journal article
WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group None. et al, (2021), JAMA
Making trials part of good clinical care: lessons from the RECOVERY trial.
Journal article
Pessoa-Amorim G. et al, (2021), Future healthcare journal, 8, e243 - e250
Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
Working paper
Horby P. et al, (2021), Lancet (London, England), 398
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Working paper
RECOVERY Collaborative Group None., (2021), Lancet (London, England), 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet (London, England), 397, 1637 - 1645
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
LANDRAY M. et al, (2021), The Lancet
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study.
Journal article
Morris EJA. et al, (2021), The lancet. Gastroenterology & hepatology, 6, 199 - 208
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet (London, England), 397, 605 - 612
Dexamethasone in Hospitalized Patients with Covid-19.
Journal article
RECOVERY Collaborative Group None. et al, (2021), The New England journal of medicine, 384, 693 - 704
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
Horby P. et al, (2020)